Knowledge Center
Article / Feb 01, 2015
The Time Has Come
Source:
PMPS, 2015, February, pp. 30 - 33
The respiratory drug sector is experiencing a surge of interest as companies seek to capitalise on the rapidly growing market.
With new product launches and novel formulation combinations in development, inhaled drug delivery is reaching far beyond its origins in asthma and COPD treatments.
Related links
Also in the Knowledge Center
Scientific Article
/ Jan 01, 2003
Vitro characterization of jet-milled and in-situ-micronized fluticasone-17-propionate
Read more
Scientific Article
/ Jan 01, 1991
Structure of [RhH2(PPh3)2(bipy)]Cl (bipy = 2,2'-bipyridyl) from multinuclear NMR studies
Read more
Scientific Article